Cumberland Pharmaceuticals Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
Cumberland Pharmaceuticals Inc. (CPIX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of -1.86% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2025-03-07
- Cumberland Pharmaceuticals Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2024 was -1.86%.
- Cumberland Pharmaceuticals Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2023 was -6.51%.
- Cumberland Pharmaceuticals Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2022 was -2.58%.
- Cumberland Pharmaceuticals Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2021 was -4.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -1.86% 10-K · filed 2025-03-07 | |
| 2023-12-31 | -6.51% 10-K · filed 2025-03-07 | |
| 2022-12-31 | -2.58% 10-K · filed 2024-03-13 | -2.00% 10-K · filed 2023-03-13 |
| 2021-12-31 | -4.00% 10-K · filed 2023-03-13 | |
| 2020-12-31 | -7.00% 10-K · filed 2022-03-11 | |
| 2019-12-31 | 1.00% 10-K · filed 2022-03-11 | |
| 2018-12-31 | -1.00% 10-K · filed 2021-03-12 | |
| 2017-12-31 | 1.00% 8-K · filed 2020-12-10 | |
| 2016-12-31 | -2.00% 10-K · filed 2019-03-12 | |
| 2015-12-31 | 7.00% 10-K · filed 2018-03-09 | 10.00% 10-K · filed 2016-03-14 |
| 2014-12-31 | 1.00% 10-K · filed 2017-03-13 | |
| 2013-12-31 | 0.00% 10-K · filed 2016-03-14 | |
| 2012-12-31 | 3.00% 10-K · filed 2015-03-09 | |
| 2011-12-31 | 2.00% 10-K · filed 2014-03-11 | |
| 2010-12-31 | 4.00% 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |